The latest biotech news

News and Trends 13 Jun 2018

French Biotech Develops a New Generation of Safer CAR-T Cells

Cellectis is developing a new type of chimeric antigen receptor that could improve the production and safety of CAR-T cell therapies generated from both patient and donor cells. Cellectis, a French biotech focused on developing CAR-T therapies from donor cells, has published a study in the journal Scientific Reports describing technological advances that could improve the […]

June 13, 2018 - 2 minutesmins - By Alexander Burik

pluristem cell therapy peripheral artery disease

News and Trends 13 Jun 2018

Placenta Cell Therapy Improves Mobility in Patients with Peripheral Artery Disease

The Israeli biotech Pluristem has Phase II data indicating that its cell therapy made of placenta cells can help patients suffering from peripheral artery disease recover their mobility. The trial, run in the US, Germany, South Korea and Israel, enrolled 172 patients with intermittent claudication, an early stage of peripheral artery disease where the legs […]

June 13, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 12 Jun 2018

Spider Silk Shows Promise in Vaccine Field

Swiss and German scientists have engineered spider-silk microparticles that can be used to protect a vaccine particle, allow it to enter immune cells and trigger T-cell immunity without toxic effects. The team, partnered by AMSilk — the German biotech behind Adidas’ biodegradable shoes, hopes their technique will allow more targeted and stable vaccines against difficult targets […]

June 12, 2018 - 3 minutesmins - By Helen Albert

News and Trends 11 Jun 2018

Scientists Warn CRISPR Therapy Could Cause Cancer as First Human Trials Take Place

A study at Karolinska Institutet in Sweden has revealed that CRISPR-Cas9 gene editing could favor mutations in the most common cancer-causing gene. What does it mean for the first CRISPR therapy trials in humans? CRISPR-Cas9 has taken the life sciences field by storm, making gene editing simpler and faster than ever. Although CRISPR-Cas9 gene […]

June 11, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 11 Jun 2018

Danish Biotech Plans Phase II Study to Fight A Rare Eating Disorder

Saniona, a biotech focused on ion channel research, plans to test its lead candidate in a Phase IIa study for the rare eating disorder hypothalamic obesity. Saniona, based in Copenhagen, plans to start a Phase IIa trial testing its product, Tesomet, a combination of tesofensine and metoprolol, in hypothalamic obesity. The study would complement the […]

June 11, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 8 Jun 2018

People with Innate Resistance to HIV Could Provide a Functional HIV Cure

In the process of studying HIV-infected patients who naturally don’t need therapy to control the virus, scientists have found what could become a functional cure for HIV infections. A team of researchers from France, Italy, the UK and Australia has identified a molecule that could be transferred to HIV-positive people to help […]

June 8, 2018 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 7 Jun 2018

Microbiome Company Enters $534M Deal With Genentech To Develop Treatments for IBD

UK biotech Microbiotica has entered into a multi-year collaboration with Genentech, one of the world’s first biotechs, to develop microbiome-based treatments for inflammatory bowel disease. Microbiotica, based in Cambridge, UK has entered into a collaboration with Genentech that could be worth up to €452M ($534M), a formidable amount in the microbiome space, with an undisclosed […]

June 7, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 6 Jun 2018

Best of European Biotech at ASCO 2018

Not able to attend the biggest cancer conference of the year? No problem. We have summarized what we think are the most interesting therapy developments presented by European biotech’s at ASCO this year. Once again, the cream of the cancer specialist crop gathered in Chicago to discuss and present the latest findings in cancer research at […]

June 6, 2018 - 5 minutesmins - By Helen Albert

News and Trends 6 Jun 2018

German DNA Treatment Reduces Ulcerative Colitis Symptoms

Sterna Biologicals has obtained positive Phase IIa data for an ulcerative colitis treatment that uses DNA to inhibit inflammatory proteins, which could add to the diverse approaches being developed to treat inflammatory bowel disease. Sterna Biologicals, based in Marburg, Germany, has clinical data showing its ulcerative colitis treatment reduced the severity of the disease compared […]

June 6, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 5 Jun 2018

British Researchers Regenerate Tooth Enamel With Biopolymers

Researchers at Queen Mary University London have found a way to grow mineralized materials that can be used to regenerate hard tissue like dental enamel. British researchers have created a material that can be used as an artificial dental enamel to prevent and treat tooth decay or tooth sensitivity. To create the enamel, the scientists […]

June 5, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 5 Jun 2018

French Biotech Raises €40M to Fight Hepatitis B and NASH

Enyo Pharma has completed a Series B financing round to start Phase II trials by the end of this year testing its lead compound in two different forms of liver disease. Enyo Pharma, based in Lyon, has raised €40M from OrbiMed and other investors to start two Phase II trials testing its lead drug candidate […]

June 5, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 4 Jun 2018

British Company Gets a $100M Boost to Develop a Surgical Robotic Arm

CMR Surgical has raised an impressive Series B round to develop a robotic arm to help during surgery that mirrors the movement of a human arm. CMR Surgical, based in Cambridge, UK, has raised $100M (€85M) in Series B funding to bring its surgical robot technology closer to a market launch in Europe and the US. […]

June 4, 2018 - 2 minutesmins - By Alexander Burik

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

French Biotech Develops a New Generation of Safer CAR-T Cells

Placenta Cell Therapy Improves Mobility in Patients with Peripheral Artery Disease

Spider Silk Shows Promise in Vaccine Field

Scientists Warn CRISPR Therapy Could Cause Cancer as First Human Trials Take Place

Danish Biotech Plans Phase II Study to Fight A Rare Eating Disorder

People with Innate Resistance to HIV Could Provide a Functional HIV Cure

Microbiome Company Enters $534M Deal With Genentech To Develop Treatments for IBD

Best of European Biotech at ASCO 2018

German DNA Treatment Reduces Ulcerative Colitis Symptoms

British Researchers Regenerate Tooth Enamel With Biopolymers

French Biotech Raises €40M to Fight Hepatitis B and NASH

British Company Gets a $100M Boost to Develop a Surgical Robotic Arm

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!